|
Ipilimumab and nivolumab Clinical Trials
3 actively recruiting trials across 2 locations
▲ +1 trial since May 2026
Also known as: Yervoy and Opdivo
Pipeline
Phase 1: 1Phase 2: 1Phase 1/2: 1
Top Sponsors
- University of Hawaii1
- The Netherlands Cancer Institute1
- Orion Corporation, Orion Pharma1
Indications
- Cancer3
- Liver Disease1
- Neoplasia1
- Tumors1
- NSCLC (Advanced Non-small Cell Lung Cancer)1
Other1 trial
Honolulu, Hawaii1 trial
Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer
The Queen's Medical Center
Phase 1
Irving, Texas1 trial
A 2-part Phase 1/2 Open-label Trial on ODM-212
NEXT Oncology
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.